Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants

AIM: Direct‐acting oral anticoagulants (DOACs) have become available for the prevention of stroke in patients with atrial fibrillation (AF). Conflicting results have been published on the risk of acute myocardial infarction (AMI) with the use of DOACs in comparison with vitamin K antagonists (VKAs)....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Clin Pharmacol
Autors principals: Stolk, Leo M., de Vries, Frank, Ebbelaar, Chiel, de Boer, Anthonius, Schalekamp, Tom, Souverein, Patrick, ten Cate‐Hoek, Arina, Burden, Andrea M.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2017
Matèries:
Pharmacoepidemiology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6495191/
https://ncbi.nlm.nih.gov/pubmed/28326589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13264
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars